SPRYNasdaq United States
Market cap
$611.708 M
$6.16 +10.99%
Close of 7 Aug 2026
Revenue
$84.3M
#2575 by revenue
Earnings
-$171.3M
Loss-making
Shares outstanding
99,297,307
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for ARS Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.